amiodarone and ranolazine

amiodarone has been researched along with ranolazine in 34 studies

Research

Studies (34)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (8.82)	29.6817
2010's	29 (85.29)	24.3611
2020's	2 (5.88)	2.80

Authors

Authors	Studies
Freiwald, S; Jiang, Y; Jones, JP; Kaspera, R; Katayama, J; Lee, CA; Smith, E; Totah, RA; Walker, GS	1
Dalvie, D; Loi, CM; Smith, DA	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Rosovski, U; Viskin, S	1
Antzelevitch, C; Belardinelli, L; Burashnikov, A; Di Diego, JM; Zygmunt, AC	1
DiMarco, JP; Mason, PK	1
Antzelevitch, C; Belardinelli, L; Burashnikov, A; Sicouri, S	1
Dobrev, D; Nattel, S	1
Chirkov, YY; Horowitz, JD; Kennedy, JA; Sverdlov, AL	1
Antzelevitch, C; Belardinelli, L; Burashnikov, A; Di Diego, JM; Sicouri, S	1
Brachmann, J; Ritscher, G; Simon Demel, K; Simon, H; Turschner, O	1
Ayalloore, SG; LeLorier, P	1
Miles, RH; Murdock, DK; Passman, R	1
Anderson, JL; Bair, TL; Bunch, TJ; Crandall, BG; Day, JD; Lappe, DL; Mader, KM; Mahapatra, S; May, HT; Molden, J; Muhlestein, JB; Murdock, D; Osborn, JS; Weiss, JP	1
Mullard, A	1
Fragakis, N; Geleris, P; Katritsis, DG; Koskinas, KC; Pagourelias, ED; Zografos, T	1
Eckardt, L; Vogler, J	1
Saklani, P; Skanes, A	1
Belardinelli, L; Kanas, AF; Nearing, BD; Pagotto, VP; Sobrado, MF; Verrier, RL; Zeng, D	1
Aidonidis, I; Chryssagis, K; Daskalopoulos, ME; Daskalopoulou, SS; Lenos, A; Molyvdas, PA; Simopoulos, V; Skoularingis, I; Tagarakis, GI; Tsilimingas, NB	1
Breithardt, G; Eckardt, L; Frommeyer, G; Kaese, S; Kaiser, D; Milberg, P; Uphaus, T	1
Arellano, AL; Cereza, G; Figueras, A; Montané, E; Tarapués, M	1
Fragakis, N; Katritsis, D; Koskinas, KC; Skeberis, V; Vassilikos, V	1
Ravens, U	1
Belardinelli, L; Camm, AJ; Karwatowska-Prokopczuk, E; Kowey, P; Olmsted, A; Reiffel, JA; Rosero, S; Zareba, W; Zeng, D	1
Capucci, A; Guerra, F; Matassini, MV; Scappini, L; Urbinati, A	1
Belardinelli, L; Braun, I; Danner, BC; Dobrev, D; Fischer, TH; Frey, N; Gummert, J; Hartmann, N; Hasenfuss, G; Maier, LS; Mason, FE; Pabel, S; Renner, A; Schotola, H; Sossalla, S; Voigt, N	1
Nguyen, E; White, CM	1
Aidonidis, I; Daskalopoulou, SS; Giamouzis, G; Hatziefthimiou, A; Skoularigis, I; Triposkiadis, F; Tsanaxidis, N	1
Al-Khatib, SM; Allen LaPointe, NM; Curtis, LH; Hammill, BG; Mi, X; Pokorney, SD	1
Ariano, C; Cioppa, C; De Vecchis, R; Giasi, A	1
Aidonidis, I; Dipla, K; Hatziefthimiou, A; Hevas, A; Simopoulos, V; Skoularigis, I; Tsilimingas, N	1
Aidonidis, I; Dipla, K; Hatziefthimiou, A; Molyvdas, PA; Simopoulos, V; Stamatiou, R; Stravela, S	1
Bove, T; Cilenti, F; Copetti, R; Cristiani, L; Guglielmo, N; Orso, D; Santangelo, S	1

Reviews

12 review(s) available for amiodarone and ranolazine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
New pharmacological agents for arrhythmias. Circulation. Arrhythmia and electrophysiology, 2009, Volume: 2, Issue:5 Topics: Acetanilides; Adenosine A1 Receptor Agonists; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Benzofurans; Clinical Trials as Topic; Dronedarone; Humans; Ivabradine; Piperazines; Pyrrolidines; Ranolazine	2009
New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet (London, England), 2010, Apr-03, Volume: 375, Issue:9721 Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Atrial Fibrillation; Dronedarone; Humans; Piperazines; Pyrrolidines; Ranolazine; Renin-Angiotensin System	2010
Modulation of myocardial metabolism: an emerging therapeutic principle. Current opinion in cardiology, 2010, Volume: 25, Issue:4 Topics: Acetanilides; Amiodarone; Cardiovascular Agents; Heart Failure; Humans; Hypertrophy, Left Ventricular; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardial Reperfusion; Myocardium; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents	2010
[New developments in the antiarrhythmic therapy of atrial fibrillation]. Herzschrittmachertherapie & Elektrophysiologie, 2010, Volume: 21, Issue:4 Topics: Acetanilides; Aged; Amiodarone; Animals; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Drug-Related Side Effects and Adverse Reactions; Drugs, Investigational; Electrocardiography; Heart Atria; Heart Failure; Heart Ventricles; Humans; Piperazines; Potassium Channels; Pyrrolidines; Ranolazine; Sodium Channels; Stroke	2010
Pharmacology of myocardial calcium-handling. Wiener medizinische Wochenschrift (1946), 2012, Volume: 162, Issue:13-14 Topics: Acetanilides; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium; Calcium Channel Blockers; Cardiomegaly; Cardiotonic Agents; Digitalis Glycosides; Dronedarone; Electrocardiography; Heart Failure; Humans; Ion Channels; Myocardial Contraction; Piperazines; Ranolazine; Signal Transduction; Tachycardia	2012
Novel anti-arrhythmic medications in the treatment of atrial fibrillation. Current cardiology reviews, 2012, Volume: 8, Issue:4 Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Digoxin; Dronedarone; Forecasting; Heart Failure; Humans; Phenethylamines; Piperazines; Pyrrolidines; Ranolazine; Sulfonamides; Technology, Pharmaceutical; Ventricular Dysfunction, Left	2012
[New developments in the antiarrhythmic therapy of atrial fibrillation]. Herzschrittmachertherapie & Elektrophysiologie, 2014, Volume: 25, Issue:1 Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Dronedarone; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Piperazines; Pyrrolidines; Ranolazine; Sodium Channel Blockers; Treatment Outcome	2014
New anthyarrhythmic drugs for atrial fibrillation. Future cardiology, 2015, Volume: 11, Issue:6 Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Humans; Pyrrolidines; Ranolazine	2015
Novel Use of Ranolazine as an Antiarrhythmic Agent in Atrial Fibrillation. The Annals of pharmacotherapy, 2017, Volume: 51, Issue:3 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Clinical Trials as Topic; Dronedarone; Drug Therapy, Combination; Humans; Male; Ranolazine; Recurrence; Treatment Outcome	2017
Antiarrhythmic effects of ranolazine used both alone for prevention of atrial fibrillation and as an add-on to intravenous amiodarone for its pharmacological cardioversion: a meta-analysis. Minerva cardioangiologica, 2018, Volume: 66, Issue:3 Topics: Administration, Intravenous; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Agents; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Ranolazine	2018
Bayesian Network Meta-analysis of Randomized Controlled Trials on the Efficacy of Antiarrhythmics in the Pharmacological Cardioversion of Paroxysmal Atrial Fibrillation. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2023, Volume: 23, Issue:4 Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Flecainide; Humans; Network Meta-Analysis; Quinidine; Randomized Controlled Trials as Topic; Ranolazine; Systematic Reviews as Topic; Verapamil	2023

Trials

6 trial(s) available for amiodarone and ranolazine

Article	Year
Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation. The American journal of cardiology, 2012, Sep-01, Volume: 110, Issue:5 Topics: Acetanilides; Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Piperazines; Proportional Hazards Models; Prospective Studies; Ranolazine; Safety Management; Severity of Illness Index; Treatment Outcome	2012
Ranolazine enhances the antiarrhythmic activity of amiodarone by accelerating conversion of new-onset atrial fibrillation after cardiac surgery. Angiology, 2014, Volume: 65, Issue:4 Topics: Acetanilides; Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiopulmonary Bypass; Coronary Artery Bypass; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Elective Surgical Procedures; Female; Greece; Humans; Infusions, Intravenous; Male; Middle Aged; Piperazines; Prospective Studies; Ranolazine; Single-Blind Method; Time Factors; Treatment Outcome	2014
Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014, Volume: 16, Issue:7 Topics: Acetanilides; Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Greece; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Piperazines; Prospective Studies; Ranolazine; Single-Blind Method; Time Factors; Treatment Outcome	2014
The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism. Circulation. Arrhythmia and electrophysiology, 2015, Volume: 8, Issue:5 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Dronedarone; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Pacemaker, Artificial; Ranolazine; Sodium Channel Blockers; Treatment Outcome	2015
Ranolazine Added to Amiodarone Facilitates Earlier Conversion of Atrial Fibrillation Compared to Amiodarone-Only Therapy. Pacing and clinical electrophysiology : PACE, 2017, Volume: 40, Issue:4 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Ranolazine; Sodium Channel Blockers; Treatment Outcome	2017
Amiodarone plus Ranolazine for Conversion of Post-Cardiac Surgery Atrial Fibrillation: Enhanced Effectiveness in Reduced Versus Preserved Ejection Fraction Patients. Cardiovascular drugs and therapy, 2018, Volume: 32, Issue:6 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Drug Therapy, Combination; Female; Greece; Heart Rate; Humans; Male; Middle Aged; Prospective Studies; Ranolazine; Single-Blind Method; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left	2018

Other Studies

16 other study(ies) available for amiodarone and ranolazine

Article	Year
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:5 Topics: Amiodarone; Astemizole; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Danazol; Drug Discovery; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Methylation; Microsomes, Liver; Models, Biological; Molecular Structure; Substrate Specificity; Tandem Mass Spectrometry; Terfenadine	2012
Which metabolites circulate? Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5 Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations	2013
The degree of potassium channel blockade and the risk of torsade de pointes: the truth, nothing but the truth, but not the whole truth. European heart journal, 2005, Volume: 26, Issue:6 Topics: Acetanilides; Amiodarone; Anti-Arrhythmia Agents; Humans; Piperazines; Potassium Channel Blockers; Ranolazine; Research Design; Torsades de Pointes; Verapamil	2005
Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation. Annals of the New York Academy of Sciences, 2008, Volume: 1123 Topics: Acetanilides; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dogs; Electrophysiology; Heart Atria; Humans; Lidocaine; Piperazines; Propafenone; Ranolazine; Sodium Channel Blockers; Ventricular Function	2008
Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria. Circulation. Arrhythmia and electrophysiology, 2010, Volume: 3, Issue:1 Topics: Acetanilides; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dogs; Drug Synergism; Electrophysiologic Techniques, Cardiac; Enzyme Inhibitors; In Vitro Techniques; Membrane Potentials; Piperazines; Ranolazine; Refractory Period, Electrophysiological; Sodium Channel Blockers	2010
Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation. Journal of the American College of Cardiology, 2010, Oct-05, Volume: 56, Issue:15 Topics: Acetanilides; Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Dronedarone; Drug Synergism; Drug Therapy, Combination; Piperazines; Ranolazine	2010
Letter by Ayalloore and LeLorier regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Isc Circulation, 2011, Apr-12, Volume: 123, Issue:14 Topics: Acetanilides; Acute Coronary Syndrome; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Electrocardiography; Enzyme Inhibitors; Heart Rate; Humans; Myocardial Infarction; Myocardial Ischemia; Piperazines; Predictive Value of Tests; Ranolazine; Risk Factors; Stroke Volume; Tachycardia, Ventricular; Thrombolytic Therapy	2011
Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting. The American journal of cardiology, 2011, Sep-01, Volume: 108, Issue:5 Topics: Acetanilides; Aged; Amiodarone; Atrial Fibrillation; Chi-Square Distribution; Coronary Artery Bypass; Enzyme Inhibitors; Female; Humans; Logistic Models; Male; Middle Aged; Piperazines; Ranolazine; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome; Vasodilator Agents	2011
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks. Pacing and clinical electrophysiology : PACE, 2011, Volume: 34, Issue:12 Topics: Acetanilides; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cohort Studies; Defibrillators, Implantable; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Hypoglycemia; Lidocaine; Male; Mexiletine; Middle Aged; Myocardial Ischemia; Piperazines; Ranolazine; Sotalol; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome	2011
Second chance for dronedarone after recent setback? Lancet (London, England), 2012, Feb-18, Volume: 379, Issue:9816 Topics: Acetanilides; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Clinical Trials Data Monitoring Committees; Contraindications; Dronedarone; Drug Approval; Drug Therapy, Combination; Electrocardiography; Europe; Humans; Piperazines; Ranolazine; Sodium Channel Blockers; Survival Analysis; United States	2012
Low doses of ranolazine and dronedarone in combination exert potent protection against atrial fibrillation and vulnerability to ventricular arrhythmias during acute myocardial ischemia. Heart rhythm, 2013, Volume: 10, Issue:1 Topics: Acetanilides; Amiodarone; Animals; Atrial Fibrillation; Chromatography, High Pressure Liquid; Disease Models, Animal; Dronedarone; Drug Therapy, Combination; Electrocardiography; Hemodynamics; Piperazines; Ranolazine; Swine; Tachycardia, Ventricular	2013
Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation. Cardiovascular therapeutics, 2013, Volume: 31, Issue:6 Topics: Acetanilides; Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dronedarone; Drug Therapy, Combination; Female; Piperazines; Rabbits; Ranolazine; Refractory Period, Electrophysiological; Sotalol	2013
Serious QT interval prolongation with ranolazine and amiodarone. International journal of cardiology, 2014, Mar-01, Volume: 172, Issue:1 Topics: Acetanilides; Aged; Amiodarone; Electrocardiography; Female; Humans; Long QT Syndrome; Piperazines; Ranolazine; Sodium Channel Blockers; Torsades de Pointes	2014
The combined effects of ranolazine and dronedarone on human atrial and ventricular electrophysiology. Journal of molecular and cellular cardiology, 2016, Volume: 94 Topics: Aged; Amiodarone; Atrial Function; Calcium; Calcium Signaling; Cardiovascular Agents; Dronedarone; Drug Therapy, Combination; Female; Heart Atria; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Myocytes, Cardiac; Ranolazine; Sarcomeres; Ventricular Function	2016
Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia. The American journal of cardiology, 2017, 05-01, Volume: 119, Issue:9 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Databases, Factual; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Humans; Logistic Models; Male; Medicare Part D; Mexiletine; Ranolazine; Sodium Channel Blockers; Sotalol; Tachycardia, Ventricular; United States	2017
Ranolazine depresses conduction of rapid atrial depolarizations in a beating rabbit heart model. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2021, Volume: 62, Issue:1 Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Heart Rate; Rabbits; Ranolazine	2021